bpacnz COPD prescribing tool
Register to use all the features of this website, including selecting clinical areas of interest and
“favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
The New Zealand Laboratory Schedule and Test Guidelines
View all Issues
Antibiotics Guide, July 2013
Best Tests, July 2015
Best Practice Journal, July 2016
Urinary incontinence in women
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially,
quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features
of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
Subsidy changes for medicines used to treat patients with COPD came into effect on March 1, 2016. In this article we discuss how...
The risks and benefits of treatment with inhaled corticosteroids (ICS) are different for individual patients with COPD. There...
Dabigatran (Pradaxa) is now available in New Zealand, fully funded, without Special Authority, as an alternative oral anticoagulant...
Pharmacogenomics for General Practitioners: Time for clinical application
Bioequivalence is established by undertaking a single or in certain circumstances a number of bioequivalence studies. Most bioequivalence...
In New Zealand, Medsafe is responsible for the regulation of generic medicines. This involves evaluating the manufacturing processes,...
Antiplatelet drugs including aspirin, clopidogrel and dipyrimadole, reduce the incidence of cardiovascular events by about 20-25%...
From July 2007, Glaxo Smith Kline has distributed a new formulation of Eltroxin 50 microgram and 100 microgram. Since then, there...
• Calcium Supplementation and the risk of myocardial infarction
• Use of eGFR for drug dose adjustment•
An overview of the CYP450 system with particular reference to the metabolism of antidepressant drugs.
Explains bioequivalence, how it’s regulated in New Zealand and the main validity issues.
Can smoking cessation affect the dose of antipsychotics?Do statins cause nightmares?How important is it to give simvastatin at...
In this article we provide an overview and guidance on the management of patients taking lithium.
Pharmacogenetics: relevance in the treatment of depression
Copyright All Rights Reserved © bpacnz 2017
Follow us on facebook
View Guidelines »
Recertification programme »
Decision support for health professionals »
Info on the use of medicines in NZ »
South Island general practice support »
Practice acquisition and careers in health »